Company / Interest Expense per Share
Axsome Therapeutics, Inc. Interest Expense per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
-$0.33
FY2025
5-year range
-$0.46 / -$0.26
FY2022-FY2025
Trend
+28.2%
vs FY2024
Sector context
#42 of 43
Health Care
What the data says
Among 43 Health Care companies, Axsome Therapeutics, Inc. is in the top 2% for interest expense per share. Increased from $-0.46 to $-0.33 over the past 2 years.
Based on SEC 10-K filings.
-0.33 in FY2025.
Increased from $-0.46 to $-0.33 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 43This company -$0.33 Sector average $18.61
▼
-101.8% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share increased 28.2% year-over-year.
- Ranks #42 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.33 | +28.2% |
| FY2024 | -$0.46 | +1.0% |
| FY2023 | -$0.46 | -80.3% |
| FY2022 | -$0.26 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026